Gene · 8717
Papers2,847
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,847
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Jaceidin Inhibits Proliferation and Promotes Apoptosis in Oral Squamous Cell Carcinoma Cells by Regulating Survivin and AKT/ERK Signaling Pathways. | Int J Mol Sci | 2026 | 42737771 | PubTator, text mining | PubMed |
| Structural characterization of PAMK and its protective effect against thymic necroptosis in goslings. | Vet Q | 2026 | 42677992 | PubTator, text mining | PubMed |
| Deciphering HPV-Associated Immune Evasion in Cervical Cancer Through Multi-Omics Profiling and Computational Screening. | Anal Cell Pathol (Amst) | 2026 | 42635083 | PubTator, text mining | PubMed |
| Binding of death receptor 3 (DR3) to intracellular TRADD and TRAF2 is independent of its natural ligand, TL1A. | J Immunol | 2026 | 42522260 | PubTator, text mining | PubMed |
| Diosgenin inhibits necroptosis to alleviate NAFLD by blocking the RIPK1/RIPK3/MLKL pathway. | J Nutr Biochem | 2026 | 42323101 | PubTator, text mining | PubMed |
| Functional variants in ATF4 and PMAIP1 reveal mitochondrial apoptosis dependencies driving pancreatic cancer progression. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 42024236 | PubTator, text mining | PubMed |
| Deciphering the Chemotherapeutic Mechanism of Ferulic Acid: Insight Into the Role Against Multiple Human Cancers. | Cancer Innov | 2026 | 42016510 | PubTator, text mining | PubMed |
| Gene Expression Alterations Associated With Resveratrol-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Osteosarcoma Cancer Cells. | J Cell Mol Med | 2026 | 41937498 | PubTator, text mining | PubMed |
| Role of aging‑related cytokines in neurodegenerative disease (Review). | Int J Mol Med | 2026 | 41930561 | PubTator, text mining | PubMed |
| Electric dipole moment drives the dynamics of the TNFR1 complex I signalosome. | Nature | 2026 | 41922760 | Swiss-Prot, curated | PubMed |
| Adaptor protein supersaturation drives innate immune signaling and cell fate. | Elife | 2026 | 41873950 | PubTator, text mining | PubMed |
| ADA2-deficient cells exhibit increased levels of cell death and metabolic disturbances. | Cell Death Discov | 2026 | 41866403 | PubTator, text mining | PubMed |
| Selective Inhibition of Tumor Necrosis Factor for Attenuating Alzheimer's Disease: Strategies Targeting Neuroinflammation. | Inflammation | 2026 | 41832369 | PubTator, text mining | PubMed |
| Effect of compound kushen injection on immune function in patients with primary liver cancer: a systematic review and meta-analysis. | Front Pharmacol | 2026 | 41800103 | PubTator, text mining | PubMed |
| DAB2IP: unifying cardiovascular pathogenesis and cardiovascular brain crosstalk. | Front Cardiovasc Med | 2026 | 41798622 | PubTator, text mining | PubMed |
| TNF inhibits SARS-CoV-2 induced cell-cell fusion through activating the SDC4-RhoA signaling to promote actin bundles formation. | Cell Insight | 2026 | 41783041 | PubTator, text mining | PubMed |
| Osteoarthritis: molecular pathogenesis and potential therapeutic options. | Signal Transduct Target Ther | 2026 | 41781374 | PubTator, text mining | PubMed |
| Molecular mechanisms and therapies for tumor inhibition through the arginine metabolism pathway. | Front Oncol | 2026 | 41756322 | PubTator, text mining | PubMed |
| Dissecting Cell Death Pathways in Influenza A Virus Infection: Comparative Insights from Human Models. | Viruses | 2026 | 41754589 | PubTator, text mining | PubMed |
| High-Throughput Sequencing Decodes tsRNA Landscapes: Insights into Cancer Biomarkers and Therapeutic Targets. | Int J Mol Sci | 2026 | 41752084 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8717/papers